Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the official name of the novel coronavirus that is currently causing a worldwide pandemic. COVID-19 is the official name of the respiratory disease caused by SARS-CoV-2. SARS-CoV-2 is highly contagious and is transmitted through respiratory droplets and contact with contaminated surfaces.
More information about COVID-19 can be found at the Center for Disease Control and Prevention CDC websites:
Although several studies are still in progress, according to the March 10th, 2020 study published in the Annals of Internal Medicine, the mean incubation period for COVID-19 as measured from publicly confirmed cases is 5 days.
Also called a molecular test, this COVID-19 test detects genetic material of the virus using a lab technique called polymerase chain reaction (PCR)
The CDC stated that “Clinicians should use their judgment to determine if a patient has signs and symptoms compatible with COVID-19 and whether the patient should be tested”. In addition, priority testing should be given to:
- Hospitalized patients who have signs and symptoms compatible with COVID-19 in order to inform decisions related to infection control.
- Other symptomatic individuals such as, older adults (age ≥ 65 years) and individuals with chronic medical conditions and/or an immunocompromised state that may put them at higher risk for poor outcomes (e.g., diabetes, heart disease, receiving immunosuppressive medications, chronic lung disease, chronic kidney disease).
- Any persons including healthcare personnel, who within 14 days of symptom onset had close contact with a suspect or laboratory-confirmed COVID-19 patient, or who have a history of travel from affected geographic areas within 14 days of their symptom onset.
ATVIVO offers the Applied Biosystems TaqPath COVID-19 test which is a highly sensitive multiplex diagnostic solution for real time PCR detection of RNA from the SARS-CoV-2 Virus. The polymerase chain reaction (PCR) technology tests detect disease by looking for traces of the virus genetic material on a sample most often collected via a nose of throat swab. The US Centers for Disease Control and Prevention (CCD) considers PCR tests the “gold standard".